Venetoclax 100mg tablets
NHS hospitals in England used £71,823,871 of indicative cost of Venetoclax 100mg tablets in the 12 months to July 2026, about 0.3% of all hospital medicines spend. That is down 5.3% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Venetoclax 100mg tablets: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to July 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Venetoclax 100mg tablets most
By indicative cost over the 12 months to July 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| University Hpls Of Leicester Nhs Trust | £1,969,871 |
| Western Sussex Hospitals Nhs Found Trust | £1,920,822 |
| Oxford University Hospitals Nhs Ft | £1,874,766 |
| University Hospital Southampton Nhs Ft | £1,864,503 |
| Norfolk & Norwich University Hpl Nhs Trt | £1,776,797 |
| Somerset P/Ship Nhs Foundation Trust | £1,528,644 |
| Nottingham University Hospitals Trust | £1,432,941 |
| The Royal Marsden Nhs Foundation Trust | £1,372,004 |
| York Teaching Hospital Nhs Ft | £1,303,668 |
| South Tyneside And Sunderland Nhs Ft | £1,302,043 |
The primary-care picture
No confident match to a community-dispensed medicine was found for this product, so no primary-care comparison is shown. SCMD products are recorded at product level, which does not always map cleanly to a BNF substance.